Allerotherapeutics
1 known investors
Allero Therapeutics develops non-invasive immunotherapies for immune-mediated disorders such as autoimmune and allergic diseases and anti-drug antibody (ADA) responses. Its SOMIT (Specific OroMucosal ImmunoTherapy) platform is designed to induce long-lasting antigen-specific immune tolerance.
Investors · 1
Frequently asked questions
- What does Allerotherapeutics do?
- Allero Therapeutics develops non-invasive immunotherapies for immune-mediated disorders such as autoimmune and allergic diseases and anti-drug antibody (ADA) responses. Its SOMIT (Specific OroMucosal ImmunoTherapy) platform is designed to induce long-lasting antigen-specific immune tolerance.
- Who are Allerotherapeutics's investors?
- Allerotherapeutics's investors include Curie Capital.